Mambolo Clinic
Welcome,         Profile    Billing    Logout  
 3 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Leigh, Bailah
NCT02876328 / 2019-001308-39: Partnership for Research on Ebola VACcinations

Completed
2
4789
RoW
Ad26.ZEBOV, rHAd26, MVA-BN-Filo, MVA, MVA-mBN226B, rVSVΔG-ZEBOV-GP, rVSV, V920, Placebo, rVSV boost
National Institute of Allergy and Infectious Diseases (NIAID), Partnership for Research on Ebola Virus in Liberia (PREVAIL), Institut National de la Santé Et de la Recherche Médicale, France, London School of Hygiene and Tropical Medicine, European and Developing Countries Clinical Trials Partnership (EDCTP)
Ebola Virus Disease
12/19
12/23
NCT05284097: Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study

Active, not recruiting
2
133
RoW
Ad26.ZEBOV, MVA-BN-Filo, VAC52150
London School of Hygiene and Tropical Medicine, University of Sierra Leone, Janssen Vaccines & Prevention B.V.
Virus Diseases, Hemorrhagic Fever, Ebola, Infections, Hemorrhagic Fevers, Viral, RNA Virus Infections, Filoviridae Infections, Mononegavirales Infections, Vaccines, Immunologic Factors, Physiological Effects of Drugs, Ebola
12/23
05/24
NCT03820739: EBOVAC-Salone Extension

Completed
N/A
653
RoW
Follow-up, Blood sample collection
London School of Hygiene and Tropical Medicine, University of Sierra Leone, Janssen Vaccines & Prevention B.V., Institut National de la Santé Et de la Recherche Médicale, France, Universiteit Antwerpen
Ebola Virus Disease
06/22
07/22

Download Options